AK

Ankit Khandelwal

Active Director Designated Partner DIN 08300007
DIN 08300007 First appointment Dec 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankit Khandelwal

Data last updated:

Ankit Khandelwal is a Designated Partner at Curegen Lifescience Llp (since 2018). The company operates in Business Services.

DIN 08300007
Primary Designation Designated Partner
Industry Business Services
First Appointment 11 Dec 2018
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Dec 20182016Active

Board colleagues of Ankit Khandelwal

NameDINCompanyDesignation
Manish Khandelwal07441892Curegen Lifescience LlpDesignated Partner
Punit Kumar Khandelwal07439913Curegen Lifescience LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curegen Lifescience Llp
Premium access

Shareholding and investment profile for Ankit Khandelwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Khandelwal

Ankit Khandelwal currently holds 1 directorship: Curegen Lifescience Llp (Designated Partner, since 11 Dec 2018).

Ankit Khandelwal was first appointed on 11 Dec 2018 as Designated Partner at Curegen Lifescience Llp.

The current boards of Ankit Khandelwal's companies include Manish Khandelwal (Curegen Lifescience Llp), Punit Kumar Khandelwal (Curegen Lifescience Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available